Efficacy and safety of eltrombopag in the treatment of cancer therapy-induced thrombocytopenia: a large-scale, multicenter, retrospective study in China.

Promacta (eltrombopag) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42708124

Bingjie Ding; Hongming Huang; Hu Zhou; Huo Zhang; Li Li; Likun Zheng; Yan Lin; Yunfei Chen

Sep 9, 2026